JenaValve Technology Revenue and Competitors

Claim your profile

Location

$199.1M

Total Funding

Estimated Revenue & Valuation

  • JenaValve Technology's estimated annual revenue is currently $49.3M per year.(i)
  • JenaValve Technology's estimated revenue per employee is $313,750
  • JenaValve Technology's total funding is $199.1M.

Employee Data

  • JenaValve Technology has 157 Employees.(i)
  • JenaValve Technology grew their employee count by 28% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M78-4%N/AN/A
#2
$3.5M34-8%N/AN/A
#3
$5.5M2283%N/AN/A
#4
$3.3M320%N/AN/A
#5
$5.8M23-28%N/AN/A
#6
$49.7M198-13%N/AN/A
#7
$9.8M39N/AN/AN/A
#8
$2.9M2875%N/AN/A
#9
$27.4M10911%N/AN/A
#10
$49.3M15728%$199.1MN/A

keywords:N/A

$199.1M

Total Funding

157

Number of Employees

$49.3M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

JenaValve Technology News

2022-04-19 - What Target Market Does Bioprosthetics Have? LeMaitre Vascular ...

... including new technologies, industry drivers, challenges, ... Inc., Edwards Lifesciences Corporation, JenaValve Technology GmbH.

2022-04-17 - Heart Valve Devices Market Size And Forecast | Abbott, CryoLife ...

... Boston Scientific, Edward Lifesciences, TTK HealthCare, JenaValve Technology, Medtronic, Neovasc, Sorin Group, Micro Interventional.

2022-04-06 - Heart Valve Repair and Replacement Devices Market to grow at a ...

... Boston Scientific Corp., Colibri Heart Valve LLC, Edwards Lifesciences Corp., JenaValve Technology Inc., LivaNova Plc, Medtronic Plc,...

2020-02-10 - JenaValve Finds $50M Funding

Irvine-based JenaValve Technology, which develops aortic valve replacements, said last week that it has raised $50M in a financing round. The funding was led by Bain Capital Life Sciences, and also included existing investors Andera Partners, Gimv, Legend Capital, NeoMed Management, RMM, Valianc ...

2020-02-07 - TAVR developer JenaValve nets $50M from Bain Capital Life Sciences

Heart valve maker JenaValve Technology has raised $50 million in new venture capital funding, not long after receiving a breakthrough device designation from the FDA for its transcatheter aortic valve replacement (TAVR) system. Sponsored by Agilent Technologies How would you like to win free b ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.7M1576%N/A
#2
$43.9M15715%N/A
#3
$56.1M158-4%N/A
#4
$30.2M15913%N/A
#5
$24.6M16043%N/A